NASDAQ:FEED Nanovibronix (FEED) Stock Price, News & Analysis $0.22 -0.03 (-12.00%) As of 03:59 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsSEC Filings About Nanovibronix Stock (NASDAQ:FEED) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Nanovibronix alerts:Sign Up Key Stats Today's Range$0.22▼$0.2650-Day Range$0.22▼$5.0852-Week Range$0.12▼$73.08Volume7,424 shsAverage Volume361,558 shsMarket Capitalization$203.28 thousandP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview NanoVibronix, Inc. is a medical device company focused on developing and commercializing noninvasive therapeutic ultrasound products. Its technology is designed to deliver low-intensity ultrasound through the skin for applications involving pain management, wound care and other therapeutic needs. The company’s product portfolio has included PainShield, a wearable ultrasound device intended to provide localized relief for chronic and acute pain, and WoundShield, a device designed to support the treatment of chronic and difficult-to-heal wounds. NanoVibronix has marketed its products through healthcare providers, distributors and direct-to-consumer channels. NanoVibronix has operated in the United States and international markets, including through distribution relationships in Europe and other regions. Public references generally identify NanoVibronix under the ticker symbol NAOV; the symbol FEED does not appear to correspond to the company.AI Generated. May Contain Errors. Read More Nanovibronix Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks8th Percentile Overall ScoreFEED MarketRank™: 0.38327526132 of 5 starsNanovibronix scored higher than 8% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.5 / 5Analyst RatingSell Consensus RatingNanovibronix has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageNanovibronix has received no research coverage in the past 90 days.Read more about Nanovibronix's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Nanovibronix is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Nanovibronix is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioNanovibronix has a P/B Ratio of 0.00. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.99% of the float of Nanovibronix has been sold short.Short Interest Ratio / Days to CoverNanovibronix has a short interest ratio ("days to cover") of 0.08, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Nanovibronix has recently decreased by 81.64%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldNanovibronix does not currently pay a dividend.Dividend GrowthNanovibronix does not have a long track record of dividend growth. News and Social Media0.0 / 5News Sentiment0.00 News Coverage This WeekMarketBeat has tracked 3 news articles for Nanovibronix this week, compared to 2 articles on an average week.Search InterestOnly 4 people have searched for FEED on MarketBeat in the last 30 days. This is a decrease of -20% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Nanovibronix to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership0.6 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Nanovibronix insiders have not sold or bought any company stock.Percentage Held by Insiders12.20% of the stock of Nanovibronix is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions16.39% of the stock of Nanovibronix is held by institutions.Read more about Nanovibronix's insider trading history. Receive FEED Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nanovibronix and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. FEED Stock News HeadlinesReviewing Koninklijke Philips (NYSE:PHG) & Nanovibronix (NASDAQ:FEED)October 29 at 3:58 AM | americanbankingnews.comNanovibronix (NASDAQ:FEED) versus Integra LifeSciences (NASDAQ:IART) Head-To-Head ComparisonOctober 28 at 2:46 AM | americanbankingnews.comReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and stinging losses? Dave Aquino is giving away the exact 11-hour options strategy he uses in volatile markets. You get the plain English blueprint behind the strategy and the very same "rinse and repeat" ticker he's traded nearly 900 times with a 95.3% success rate. It's so simple to understand, you could trade it tomorrow.October 29 at 1:00 AM | Base Camp Trading (Ad)ENvue Medical Issues Letter to ShareholdersOctober 26 at 8:43 AM | theglobeandmail.comENvue Medical Provides Nasdaq Listing UpdateSeptember 15, 2026 | globenewswire.comENvue Medical Resumes U.S. Commercial Shipments of NanoVibronix PainShield® and Begins Fulfilling Open Distributor OrdersSeptember 9, 2026 | globenewswire.comFEED Share News TodaySeptember 8, 2026 | uk.investing.comENvue Medical Selected to Exhibit ENvue™ Navigation Platform at Vizient Innovative Technology ExchangeSeptember 2, 2026 | globenewswire.comSee More Headlines FEED Stock Analysis - Frequently Asked Questions How have FEED shares performed this year? Nanovibronix's stock was trading at $27.60 on January 28, 2026. Since then, FEED stock has decreased by 99.2% and is now trading at $0.2323. When did Nanovibronix's stock split? Nanovibronix shares reverse split on Tuesday, September 1st 2026.A 1-12 reverse split was announced. The number of shares owned by shareholders was adjusted after the market closes on Monday, August 31st 2026. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split. How do I buy shares of Nanovibronix? Shares of FEED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today10/29/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (6m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 FEED's financial health is in the Yellow zone, according to TradeSmith. FEED has been in this zone for over 6 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:FEED CIK1326706 Webnanovibronix.com Phone(914) 233-3004Fax914-376-6111Employees20Year FoundedN/AProfitability EPS (Trailing Twelve Months)($117.28) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$18.18 million Net Margins-1,093.61% Pretax Margin-1,111.94% Return on Equity-60.73% Return on Assets-48.48% Debt Debt-to-Equity RatioN/A Current Ratio0.66 Quick Ratio0.31 Sales & Book Value Annual Sales$1.93 million Price / Sales0.11 Cash FlowN/A Price / Cash FlowN/A Book Value$365.43 per share Price / Book0.00Miscellaneous Outstanding Shares924,000Free Float810,000Market Cap$214.65 thousand OptionableN/A Beta1.46 Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven.Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (NASDAQ:FEED) was last updated on 10/29/2026 by MarketBeat.com Staff. From Our PartnersFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredThe "velvet rope" stock setups hiding from regular indicatorsK.I.R.A. is a new trading engine built to flag market setups before they show up on standard charts. Former...The TradingPub | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredA free stock pick, from me to youElon's paid this chip supplier since 2012. When NVIDIA tried to buy the company, he fought the deal. Withou...Behind the Markets | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredElon Musk’s One Stock Retirement PlanStanley Druckenmiller once said you don't get rich diversifying into 50 mediocre assets - you get rich finding...Brownstone Research | SponsoredLast note from me on thisJoel Peterson's free workshop breaks down a three step, three color system that works across stocks, ETFs, gol...The Cycle Code | SponsoredThe Claude AI company doubled in value... you missed itIn May, Anthropic raised money at a $965 billion valuation. Now, ahead of its IPO, investors are reportedly di...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nanovibronix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nanovibronix With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
